Acute ischemic stroke treatment, part 1: Patient selection: "The 50% barrier and the capillary index score"

Firas Al-Ali, John Joseph Elias, Danielle E. Filipkowski, Ramón Gilberto González, James E. Faber

Research output: Contribution to journalArticle

Abstract

The current strategy for intra-arterial treatment (IAT) of acute ischemic stroke focuses on minimizing time from ictus to revascularization and maximizing revascularization. Employing this strategy has yet to lead to improved rates of successful outcomes, however. The collateral blood supply likely plays a significant role in maintaining viable brain tissue during ischemia. Based on our prior work, we believe that only approximately 50% of patients are genetically predisposed to have sufficient collaterals for a good outcome following treatment, a concept we call the 50% barrier. The Capillary Index Score (CIS) has been developed as a tool to identify patients with a sufficient collateral blood supply to maintain tissue viability prior to treatment. Patients with a favorable CIS (fCIS) may be able to achieve a good outcome with IAT beyond an arbitrary time window. The CIS is incorporated into a proposed patient treatment algorithm. For patients suffering from a large stroke without aphasia, a non-enhanced head CT should be followed by CT angiography (CTA). For patients without signs of stroke mimics or visible signs of structural changes due to large irreversible ischemia, CTA can help confirm the vascular occlusion and location. The CIS can be obtained from a diagnostic cerebral angiogram (DCA), with IAT offered to patients categorized as fCIS.

Original languageEnglish (US)
Article number083
JournalFrontiers in Neurology
Volume6
Issue numberMAR
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Patient Selection
Stroke
Therapeutics
Ischemia
Tissue Survival
Aphasia
Blood Vessels
Angiography
Head
Brain

Keywords

  • Acute ischemic stroke
  • Capillary index score (CIS)
  • Intra-arterial treatment
  • Patient selection
  • Revascularization
  • Stroke outcome
  • The 50% barrier

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Acute ischemic stroke treatment, part 1 : Patient selection: "The 50% barrier and the capillary index score". / Al-Ali, Firas; Elias, John Joseph; Filipkowski, Danielle E.; González, Ramón Gilberto; Faber, James E.

In: Frontiers in Neurology, Vol. 6, No. MAR, 083, 2015.

Research output: Contribution to journalArticle

Al-Ali, Firas ; Elias, John Joseph ; Filipkowski, Danielle E. ; González, Ramón Gilberto ; Faber, James E. / Acute ischemic stroke treatment, part 1 : Patient selection: "The 50% barrier and the capillary index score". In: Frontiers in Neurology. 2015 ; Vol. 6, No. MAR.
@article{7065206f75914564a6169c93252601ab,
title = "Acute ischemic stroke treatment, part 1: Patient selection: {"}The 50{\%} barrier and the capillary index score{"}",
abstract = "The current strategy for intra-arterial treatment (IAT) of acute ischemic stroke focuses on minimizing time from ictus to revascularization and maximizing revascularization. Employing this strategy has yet to lead to improved rates of successful outcomes, however. The collateral blood supply likely plays a significant role in maintaining viable brain tissue during ischemia. Based on our prior work, we believe that only approximately 50{\%} of patients are genetically predisposed to have sufficient collaterals for a good outcome following treatment, a concept we call the 50{\%} barrier. The Capillary Index Score (CIS) has been developed as a tool to identify patients with a sufficient collateral blood supply to maintain tissue viability prior to treatment. Patients with a favorable CIS (fCIS) may be able to achieve a good outcome with IAT beyond an arbitrary time window. The CIS is incorporated into a proposed patient treatment algorithm. For patients suffering from a large stroke without aphasia, a non-enhanced head CT should be followed by CT angiography (CTA). For patients without signs of stroke mimics or visible signs of structural changes due to large irreversible ischemia, CTA can help confirm the vascular occlusion and location. The CIS can be obtained from a diagnostic cerebral angiogram (DCA), with IAT offered to patients categorized as fCIS.",
keywords = "Acute ischemic stroke, Capillary index score (CIS), Intra-arterial treatment, Patient selection, Revascularization, Stroke outcome, The 50{\%} barrier",
author = "Firas Al-Ali and Elias, {John Joseph} and Filipkowski, {Danielle E.} and Gonz{\'a}lez, {Ram{\'o}n Gilberto} and Faber, {James E.}",
year = "2015",
doi = "10.3389/fneur.2015.00083",
language = "English (US)",
volume = "6",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "MAR",

}

TY - JOUR

T1 - Acute ischemic stroke treatment, part 1

T2 - Patient selection: "The 50% barrier and the capillary index score"

AU - Al-Ali, Firas

AU - Elias, John Joseph

AU - Filipkowski, Danielle E.

AU - González, Ramón Gilberto

AU - Faber, James E.

PY - 2015

Y1 - 2015

N2 - The current strategy for intra-arterial treatment (IAT) of acute ischemic stroke focuses on minimizing time from ictus to revascularization and maximizing revascularization. Employing this strategy has yet to lead to improved rates of successful outcomes, however. The collateral blood supply likely plays a significant role in maintaining viable brain tissue during ischemia. Based on our prior work, we believe that only approximately 50% of patients are genetically predisposed to have sufficient collaterals for a good outcome following treatment, a concept we call the 50% barrier. The Capillary Index Score (CIS) has been developed as a tool to identify patients with a sufficient collateral blood supply to maintain tissue viability prior to treatment. Patients with a favorable CIS (fCIS) may be able to achieve a good outcome with IAT beyond an arbitrary time window. The CIS is incorporated into a proposed patient treatment algorithm. For patients suffering from a large stroke without aphasia, a non-enhanced head CT should be followed by CT angiography (CTA). For patients without signs of stroke mimics or visible signs of structural changes due to large irreversible ischemia, CTA can help confirm the vascular occlusion and location. The CIS can be obtained from a diagnostic cerebral angiogram (DCA), with IAT offered to patients categorized as fCIS.

AB - The current strategy for intra-arterial treatment (IAT) of acute ischemic stroke focuses on minimizing time from ictus to revascularization and maximizing revascularization. Employing this strategy has yet to lead to improved rates of successful outcomes, however. The collateral blood supply likely plays a significant role in maintaining viable brain tissue during ischemia. Based on our prior work, we believe that only approximately 50% of patients are genetically predisposed to have sufficient collaterals for a good outcome following treatment, a concept we call the 50% barrier. The Capillary Index Score (CIS) has been developed as a tool to identify patients with a sufficient collateral blood supply to maintain tissue viability prior to treatment. Patients with a favorable CIS (fCIS) may be able to achieve a good outcome with IAT beyond an arbitrary time window. The CIS is incorporated into a proposed patient treatment algorithm. For patients suffering from a large stroke without aphasia, a non-enhanced head CT should be followed by CT angiography (CTA). For patients without signs of stroke mimics or visible signs of structural changes due to large irreversible ischemia, CTA can help confirm the vascular occlusion and location. The CIS can be obtained from a diagnostic cerebral angiogram (DCA), with IAT offered to patients categorized as fCIS.

KW - Acute ischemic stroke

KW - Capillary index score (CIS)

KW - Intra-arterial treatment

KW - Patient selection

KW - Revascularization

KW - Stroke outcome

KW - The 50% barrier

UR - http://www.scopus.com/inward/record.url?scp=84926475083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926475083&partnerID=8YFLogxK

U2 - 10.3389/fneur.2015.00083

DO - 10.3389/fneur.2015.00083

M3 - Article

AN - SCOPUS:84926475083

VL - 6

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - MAR

M1 - 083

ER -